Nataša Tošić
Full Research Professor
Laboratory for molecular biomedicine
GROUP FOR MOLECULAR BIOMEDICINE
Institute of Molecular Genetics and Genetic Engineering (IMGGE),
University of Belgrade
Vojvode Stepe 444a, 11042 Belgrade 152, Serbia
Mobile: +381 65 39 76 445
Phone: +381 11 39 76 445
Fax: +381 11 397 58 08
E-mail: natasa.tosic@imgge.bg.ac.rs
EDUCATION
2010 - PhD in Molecular Genetics and Genetic Engineering, Faculty of Biology (FB), UB (The interaction of genetic markers of proliferation, differentiation and apoptosis in acute leukemia)
2002 - M.Sc. in Molecular Genetics and Genetic Engineering, FB, UB
1998 - B.Sc. in Molecular Biology and Physisology, FB, University of Belgrade
RESEARCH EXPERIENCE
2021 - Full Research Professor, IMGGE, UB
2016 – 2021 Senior Research Associate, IMGGE, UB
2011 - 2016 - Research Associate, IMGGE, UB
2003 - 2011 - Research Assistant, IMGGE, UB
1999 - 2000 - Research Trainee, Vinca Institute, Belgrade
OTHER ACTIVITIES
2012-2021 - Teaching experience at doctoral studies at the Faculty of Biology, University of Belgrade, within the study program Molecular Biology (subjects "Molecular Genetics of Human Diseases", "Molecular Hematology" and "Personalized Medicine and Pharmacogenetics")
2019 - Member of the IMGGE Scientific Board
2013 – 2016 - Strengthening the Research Potential of IMGGE through Reinforcement of Biomedical Science of Rare Diseases in Serbia – en route for innovation, SERBORDISinn (EU-FP7-REGPOT, 316088, 2013-2016), leader of WP2c
2011 – 2019 - „Rare diseases: Molecular Pathophysiology, Diagnostic and Therapeutic Modalities and Social, Ethical and Legal Aspects“ (MESTD RS, No. III41004, 2011-2019), project manager within subprojects 3 and 4: „Diagnostic and prognostic molecular markers in lymphoproliferative diseases“ and „Molecular genetic and immunophenotypic markers of clonal transformation in hematopoietic stem cells“
RESEARCH INTEREST
Dedicated to fundamental and applied research in the field of cancer genetics with a focus on hematological malignancies. Detection of genetic changes underlying the process of carcinogenesis. Molecular markers important for the diagnosis and treatment of cancer.